Published in Health Business Week, February 16th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Pharmos.
Report 1: Pharmos Corporation (PARS) reported results for the third quarter, with a net loss of $4.2 million, or $0.22 per share, for the third quarter 2006, compared to a net loss of $3.3 million, or $0.17 per share, in the 2005 third quarter.
Cash and short-term investments totaled $35.3 million at September 30, 2006.
The acquisition of Vela Pharmaceuticals Inc. (Vela) was a major focus during the quarter. The transaction expands Pharmos'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.